全文获取类型
收费全文 | 27233篇 |
免费 | 1459篇 |
国内免费 | 59篇 |
专业分类
耳鼻咽喉 | 430篇 |
儿科学 | 1119篇 |
妇产科学 | 881篇 |
基础医学 | 4438篇 |
口腔科学 | 587篇 |
临床医学 | 2267篇 |
内科学 | 5335篇 |
皮肤病学 | 540篇 |
神经病学 | 2692篇 |
特种医学 | 1148篇 |
外国民族医学 | 14篇 |
外科学 | 3903篇 |
综合类 | 119篇 |
一般理论 | 3篇 |
预防医学 | 1388篇 |
眼科学 | 521篇 |
药学 | 1404篇 |
中国医学 | 20篇 |
肿瘤学 | 1942篇 |
出版年
2022年 | 217篇 |
2021年 | 366篇 |
2020年 | 246篇 |
2019年 | 334篇 |
2018年 | 425篇 |
2017年 | 356篇 |
2016年 | 496篇 |
2015年 | 492篇 |
2014年 | 674篇 |
2013年 | 871篇 |
2012年 | 1230篇 |
2011年 | 1299篇 |
2010年 | 650篇 |
2009年 | 712篇 |
2008年 | 1200篇 |
2007年 | 1273篇 |
2006年 | 1212篇 |
2005年 | 1234篇 |
2004年 | 1031篇 |
2003年 | 1022篇 |
2002年 | 947篇 |
2001年 | 925篇 |
2000年 | 957篇 |
1999年 | 797篇 |
1998年 | 350篇 |
1997年 | 275篇 |
1996年 | 235篇 |
1995年 | 213篇 |
1994年 | 183篇 |
1993年 | 182篇 |
1992年 | 490篇 |
1991年 | 524篇 |
1990年 | 503篇 |
1989年 | 421篇 |
1988年 | 402篇 |
1987年 | 409篇 |
1986年 | 403篇 |
1985年 | 395篇 |
1984年 | 277篇 |
1983年 | 213篇 |
1982年 | 142篇 |
1981年 | 150篇 |
1979年 | 268篇 |
1978年 | 186篇 |
1977年 | 159篇 |
1976年 | 161篇 |
1975年 | 170篇 |
1974年 | 199篇 |
1973年 | 172篇 |
1972年 | 159篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
M. Jung E. Krämer M. Grzenkowski K. Tang W. Blakemore A. Aguzzi K. Khazaie K. Chlichlia G. von Blankenfeld H. Kettenmann J. Trotter 《The European journal of neuroscience》1995,7(6):1245-1265
Replication-defective retroviruses expressing the t- neu oncogene, or a hybrid protein with the neu tyrosine kinase linked to the external region of the human epidermal growth factor receptor ( egfr-neu ), were used to establish lines of murine oligodendroglial precursor cells. Differentiation of the t- neu lines into myelin-associated glycoprotein (MAG)-positive oligodendrocytes was induced by dibutyryl cAMP, and the egfr-neu line showed limited differentiation in vitro upon withdrawal of epidermal growth factor. Cerebellar granule cell neurons expressed mitogens for the cell lines. Upon transplantation into demyelinated lesions, t- neu line cells engaged with the demyelinated axons whereas the egfr-neu line cells differentiated further and ensheathed the axons. These cell lines thus interact with neurons in vitro and in vivo and can be used as tools to define the molecules involved in different stages of neuron-glia interaction. 相似文献
23.
H. von Zitzewitz C. Düber P. Gutjahr W. Kersjes M. Thelen 《World journal of urology》1995,13(4):226-229
Summary During the past few years, a new tumor type has emerged in the pediatric and adolescent group of cancer patients, which has been designated malignant peripheral neuroectodermal tumor (MPNT). This tumor has some clinical and pathological signs in common with either soft-tissue sarcomas or classic Ewing's sarcoma, but is defined as a distinct entity because of its immunohistological characteristics. The tumor expresses neuronal markers, but the pattern varies: chromogranin, neuron-specific enolase, synaptophysin, protein S-100 and others. MPNT can occur in the urogenital region. The differential diagnosis on clinical grounds must include Ewing's and soft tissue sarcomas, and also Wilms' tumor and its variants. MPNT are often wide spread in the urogenital region when first diagnosed. Response to radiotherapy and combination chemotherapy is limited. Radical surgery is not always possible. The prognosis therefore remains rather poor at this time. A selection of MPNT patients is presented to demonstrate the various problems associated with this diagnosis. MRI and CT of all patients showed large tumors with direct infiltration of the surrounding structures. MRI is the best imaging modality for diagnosis and therapy monitoring in these tumors, because of its high soft-tissue contrast. 相似文献
24.
Comparison of three immunoassays for diagnosing sensitization to latex in children with spina bifida
B. Niggemann T. Michael A. von Moers U. Seidel R. Wahl L Jacobsen D. Scheffer U. Wahn 《Pediatric allergy and immunology》1996,7(4):164-166
As natural rubber latex (latex) has become more widespread in our environment, physicians have become increasingly aware of the problem of possible allergic reactions. Many fatal and near-fatal incidents have been reported (mainly during surgery) (1—3) and data has been published on groups frequently exposed to latex, such as patients with spina bifida (4—9), healthcare professionals (10—12) and occupationally exposed persons (13). The incidence of latex allergy in children seems to be increasing (14). Tests are therefore needed which can reliably detect sensitization to latex. Our aim was to compare the diagnostic accuracy of three commercial immunoassays for measuring specific IgE in serum to latex. 相似文献
25.
A Mertens W G Friebe B Müller-Beckmann W Kampe L Kling W von der Saal 《Journal of medicinal chemistry》1990,33(10):2870-2875
A series of substituted indolyldihydropyridazinones and related compounds 1-18 were synthesized and evaluated for positive inotropic activity. In rats, most of these indole derivatives produced a dose-related increase in myocardial contractility with little effect on heart rate and blood pressure. Compound 13, 4,5-dihydro-5-methyl-6-(2-pyridin-4-yl-1H-indol-5-yl)pyrazin-3(2H) -one (BM 50.0430), was further investigated in cats. The increase in contractility in this animal model was not mediated via stimulation of beta-adrenergic receptors. After oral administration of 1 mg/kg to conscious dogs, compound 13 and pimobendan were still active after 6.5 h. However, the cardiotonic effect of 13 was at least 2-fold that of pimobendan after this period of time. The structural requirements necessary for optimal cardiotonic activity within this novel class of indole derivatives are a heterocyclic aromatic ring in position 2, a hydrogen or a methyl group in position 3, and a dihydropyridazinone ring system in position 5 of the indole. 相似文献
26.
Andrea von Berg Renate Engelstätter Predrag Minic Miodrag Sréckovic Maria Luz Garcia Garcia Tadeusz Lato Jan H. Vermeulen Stefan Leichtl Stefan Hellbardt Thomas D. Bethke 《Pediatric allergy and immunology》2007,18(5):391-400
Ciclesonide is an onsite-activated inhaled corticosteroid (ICS) for the treatment of asthma. This study compared the efficacy, safety and effect on quality of life (QOL) of ciclesonide 160 microg (ex-actuator; nominal dose 200 microg) vs. budesonide 400 microg (nominal dose) in children with asthma. Six hundred and twenty-one children (aged 6-11 yr) with asthma were randomized to receive ciclesonide 160 microg (ex-actuator) once daily (via hydrofluoroalkane metered-dose inhaler and AeroChamber Plus spacer) or budesonide 400 microg once daily (via Turbohaler) both given in the evening for 12 wk. The primary efficacy end-point was change in forced expiratory volume in 1 s (FEV1). Additional measurements included change in daily peak expiratory flow (PEF), change in asthma symptom score sum, change in use of rescue medication, paediatric and caregiver asthma QOL questionnaire [PAQLQ(S) and PACQLQ, respectively] scores, change in body height assessed by stadiometry, change in 24-h urinary cortisol adjusted for creatinine and adverse events. Both ciclesonide and budesonide increased FEV1, morning PEF and PAQLQ(S) and PACQLQ scores, and improved asthma symptom score sums and the need for rescue medication after 12 wk vs. baseline. The non-inferiority of ciclesonide vs. budesonide was demonstrated for the change in FEV1 (95% confidence interval: -75, 10 ml, p = 0.0009, one-sided non-inferiority, per-protocol). In addition, ciclesonide and budesonide showed similar efficacy in improving asthma symptoms, morning PEF, use of rescue medication and QOL. Ciclesonide was superior to budesonide with regard to increases in body height (p = 0.003, two-sided). The effect on the hypothalamic-pituitary-adrenal axis was significantly different in favor of ciclesonide treatment (p < 0.001, one-sided). Both ciclesonide and budesonide were well tolerated. Ciclesonide 160 microg once daily and budesonide 400 microg once daily were effective in children with asthma. In addition, in children treated with ciclesonide there was significantly less reduction in body height and suppression of 24-h urinary cortisol excretion compared with children treated with budesonide after 12 wk. 相似文献
27.
Ohne Zusammenfassung 相似文献
28.
29.
Metastatic bone disease from occult carcinoma: a profile 总被引:3,自引:0,他引:3
M. Nottebaert G. U. Exner A. R. von Hochstetter A. Schreiber 《International orthopaedics》1989,13(2):119-123
Summary To assess the general profile of metastatic bone disease from occult primary carcinoma, the records of 172 patients with skeletal metastases seen between 1965 and 1985 were reviewed. In 51 patients (30%), the origin of the primary could not be identified when bone metastases were first diagnosed. This group were predominantly male with a high incidence of spinal metastases, cord compression and pathological fractures, and a significantly shorter (P<0.1) survival compared with bony metastases when the primary was known. The site of the primary was established in 33 patients (65%), mostly at autopsy. Lung carcinoma was by far the most common primary tumour in 52% of the cases, while it accounted for only 7% of those with a diagnosed primary. We believe that the onset of bony metastases from an occult source must initially raise the possibility of lung carcinoma. If the primary remains undetected, it appears justifiable to assume it to be in the lung, since the probability of a missed lung tumour being responsible for the metastases is high.
Presented in part at the International Symposium on Bone Metastases, Rome, Italy, June 1986 相似文献
Résumé Les auteurs ont revu les observations de 172 malades porteurs de métastases osseuses, vus entre 1965 et 1985, afin d'apprécier l'aspect général des métastases provenant d'un cancer primitif méconnu. Chez 51 malades (30%) l'origine du cancer primitif n'avait pu être découverte lors du diagnostic de métastase osseuse. Ce groupe était à prédominance masculine, comportant un nombre élevé d'atteintes vertébrales, de compressions médullaires et de fractures pathologiques, et un taux de survie significativement plus court (P<0,1) comparativement à celui des métastases d'un cancer primitif connu. La localisation du cancer primitif a été découverte dans 33 cas (65%), la plupart du temps à l'autopsie. Le cancer du poumon était le plus fréquemment en cause (52%), alors qu'il n'était responsable que de 7% des cas quand le cancer primitif était connu. Il semble que l'apparition de métastases osseuses d'origine inconnue doive faire évoquer d'emblée la possibilité d'un cancer du poumon. Si le cancer primitif ne peut être découvert il est vraisemblable qu'il siège au niveau du poumon, la probabilité d'un cancer du poumon méconnu, responsable des métastases, étant élevée.
Presented in part at the International Symposium on Bone Metastases, Rome, Italy, June 1986 相似文献
30.